Press Release

Contino® Authorised Clinic to help Canadians with male incontinence now open in Vancouver

bg-4

Contino® is now available through Life360 Innovations Inc.’s (Life360 Innovations) first Contino® Authorised Clinic, the Dayan Physiotherapy and Pelvic Floor Clinic in Vancouver, BC. Men with urinary incontinence (UI) can now book an independent assessment at the Dayan Clinic to determine whether Contino® is right for them.

Marcy Dayan, the owner of the Dayan Clinic, is the first Contino® Authorised Trainer.  Marcy is an experienced incontinence specialist who has been trained to perform an independent assessment to determine of whether Contino® is right for clients and, if so, conduct a personalised fitting and provide training and ongoing support on how to use the product.

Marcy is a Registered Physiotherapist with extensive experience treating UI in men. She is active in clinical practice, teaching and research and delivers the UI module of the BC Prostate Cancer Supportive Care Program.

“I am pleased to offer the Contino® as an alternative for my patients” says Marcy. “The treatment options are limited and the Contino® is a discreet and dignified alternative.”

“Marcy is a Canadian leader and pioneer in the treatment of male and female incontinence. She is a recognised expert and we are excited to introduce Marcy and her clinic as the first Contino® Authorised Trainer and Clinic,” says Robert Orr, President & CEO of Life360 Innovations.

Contino® is a self-administered licensed medical device that controls bladder leakage in men. Much more than just a device, Contino® is an integrated solution that includes personalised fitting and support from incontinence specialists, so men can get on with life.

For more information on Contino®, please visit mycontino.com or contact:

Robert Orr, President & CEO
Telephone:                              +1-604-653-0360
Toll Free North America:       +1-833-543-3311

About Life360 Innovations Inc.

Life360 Innovations imagines, manufactures and distributes Health Canada Licensed medical devices under the Contino® brand. For more information on Life360 Innovations, visit life360innovations.com.

Cautionary Disclaimer Regarding Forward-Looking Statements and Information

This news release contains certain forward-looking statements concerning Life360 Innovations Holdings Inc. and its’ wholly owned subsidiaries (collectively, the “Companies”) in future periods. Statements that are not historical fact are “forward-looking statements” as that term is defined in the United States Private Securities Litigation Reform Act of 1995 and “forward looking information” as that term is defined in National Instrument 51-102 (“NI 51-102”) of the Canadian Securities Administrators (collectively, “forward-looking statements”). This document contains certain forward-looking statements relating, but not limited to, the Company’s expectations, intentions, plans and beliefs. Forward-looking information can often be identified by forward-looking words such as “anticipate”, “believe”, “expect”, “goal”, “plan”, “intend”, “estimate”, “may”, and “will”, or similar words suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions, or statements about future events or performance. Forward-looking information may include estimates of future operations, sales, unit costs, costs of capital projects and the timing of commencement of operations that are based on current expectations that involve a number of business risks and uncertainties.

Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to, failure to establish estimated revenues, capital and operating costs varying significantly from estimates, delays in obtaining or failures to obtain required regulatory approvals, inflation, changes in exchange rates, delays in the development of projects and other factors. Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from expected results.

Shareholders and prospective investors should be aware that these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those suggested by the forward-looking statements. Shareholders are cautioned not to place undue reliance on forward-looking information. By its nature, forward-looking information involves numerous assumptions, inherent risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and various assumed future events will not occur. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking information whether as a result of new information, future events, or other such factors that affect this information, except as required by law.

Reader Interactions